Neuromedin U

Neuromedin U (NMU) is a neuropeptide that was first isolated from porcine spinal cord and named for its potent uterus-contracting activity. It is a highly conserved neuropeptide, found in a wide range of species from humans to fish. Neuromedin U has been implicated in a variety of physiological processes, including the regulation of energy homeostasis, feeding behavior, and pain perception.

Structure

Neuromedin U is a small peptide, typically consisting of 25-50 amino acids, depending on the species. The human form of Neuromedin U is a 25-amino acid peptide. The C-terminal end of the peptide is highly conserved across species, suggesting that this region is critical for its biological activity.

Function

Neuromedin U is widely distributed in the body, with high levels found in the gastrointestinal tract, pituitary gland, and central nervous system. It acts by binding to its receptors, Neuromedin U receptor 1 (NMUR1) and Neuromedin U receptor 2 (NMUR2), which are members of the G protein-coupled receptor family.

In the central nervous system, Neuromedin U is involved in the regulation of feeding behavior and energy homeostasis. It has been shown to suppress food intake and increase energy expenditure, suggesting a role in the regulation of body weight.

In the gastrointestinal tract, Neuromedin U stimulates smooth muscle contraction, particularly in the uterus and gastrointestinal tract. It also stimulates the release of acetylcholine, a neurotransmitter involved in muscle contraction.

In addition, Neuromedin U has been implicated in the regulation of pain perception. Studies have shown that it can induce pain responses when administered centrally or peripherally.

Clinical significance

Given its role in regulating feeding behavior and energy homeostasis, Neuromedin U has been investigated as a potential target for the treatment of obesity and metabolic syndrome. In addition, its role in pain perception suggests potential applications in the treatment of chronic pain conditions.